Avoid costly and risky cosmetic surgeries such as eyelid correction. Fibroblast, new revolutionary non surgical lift treatment is highly effective, remarkable alternative to surgery. Some of the conditions which may be treated by Fibroblast include:
- eyelid lifting/tightening,
- wrinkle reduction,
- neck tightening,
- reduction of the upper lip wrinkles, and
- stretch marks and scars.
During the procedure tiny plasma flash also referred as an electrical arc is being discharged from the tip of the Fibroblast handpiece. The tool itself never touches the skin however plasma flash creates a tiny dot upon the contact. There is no cuts, no blood. This innovative technology uses sublimation process, turning solid directly to gas to tighten skin tissue. Targeted tissue sublimate, causing no damage to surrounding areas or deeper skin layers. Further points are applied creating a symmetrical grid over the treatment area. Effects are noticeable right away. Full results become visible after 2-4 weeks. Patient can resume regular activities right away with minimal discomfort.
Fibroblast is virtually painless and doesn’t require anesthesia. Numbing cream is used to minimize discomfort during procedure. Side effects are minimal and complications rare. Carbon crusts, a tiny superficial dots which form directly on the skin are part of normal healing process. Correctly treated with after-cream will cause no threat and fall off 5-7 days after treatment. After-care instructions will be given to a patient following the procedure. It is very important to adhere to our after-care advice.
Face-to-face consultation is required. Fibroblast specialist will asses the best treatment plan. Possible conditions jeopardizing safe and effective procedure will be discussed.
One treatment may be sufficient. This depends on treated area size and clients expected degree of correction. Additional procedure may be performed 6-8 weeks after the first one. We strongly advise to follow our after care guidelines to minimize discomfort and ensure quick healing.